Astrana Health, Inc. (ASTH)
(Real Time Quote from BATS)
$21.54 USD
-0.03 (-0.14%)
Updated Aug 4, 2025 09:34 AM ET
1-Strong Buy of 5 1
A Value D Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Astrana Health, Inc. has a PEG ratio of 1.74 compared to the Medical - Outpatient and Home Healthcare industry's PEG ratio of 1.61.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ASTH 21.54 -0.03(-0.14%)
Will ASTH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ASTH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ASTH
ASTH vs. CHE: Which Stock Is the Better Value Option?
Wall Street Analysts Think Astrana Health, Inc. (ASTH) Could Surge 97.29%: Read This Before Placing a Bet
ASTH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks.com featured highlights Astrana Health, KT, Upbound, Noah Holdings and DXP Enterprises
All You Need to Know About Astrana Health, Inc. (ASTH) Rating Upgrade to Strong Buy
ASTH or CHE: Which Is the Better Value Stock Right Now?
Other News for ASTH
Astrana Health (ASTH) Faces Price Target Cut Amid Cost Concerns
Astrana Health price target lowered by $20 at BTIG, here's why
Astrana Health, Inc. Schedules 2025 Second Quarter Financial Results Release and Conference ...
Astrana Health Inc (ASTH) Trading Down 5.35% on Jul 18
Astrana Health Inc (ASTH) Shares Gap Down to $24.7 on Jul 11